FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 240 filers reported holding FATE THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.68 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $4,645,582 | -55.0% | 460,436 | 0.0% | 0.03% | -57.5% |
| Q3 2022 | $10,318,000 | +85.9% | 460,436 | +105.5% | 0.07% | +58.7% |
| Q2 2022 | $5,551,000 | -41.2% | 224,033 | -8.0% | 0.05% | -28.1% |
| Q1 2022 | $9,437,000 | -35.7% | 243,440 | -2.9% | 0.06% | -31.9% |
| Q4 2021 | $14,670,000 | -1.3% | 250,737 | 0.0% | 0.09% | -6.9% |
| Q3 2021 | $14,860,000 | -31.7% | 250,737 | 0.0% | 0.10% | -32.2% |
| Q2 2021 | $21,762,000 | -7.8% | 250,737 | -7.2% | 0.15% | -24.0% |
| Q1 2021 | $23,592,000 | -3.9% | 270,107 | -0.0% | 0.20% | +1.0% |
| Q4 2020 | $24,562,000 | – | 270,111 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARCH Venture Management, LLC | 2,073,190 | $26,599,000 | 26.59% |
| Polaris Venture Management Co. V, L.L.C. | 1,823,186 | $23,391,000 | 24.97% |
| Casdin Capital, LLC | 2,550,000 | $32,717,000 | 5.60% |
| Redmile Group, LLC | 10,359,666 | $132,915,000 | 5.34% |
| Aquilo Capital Management, LLC | 697,096 | $8,944,000 | 4.33% |
| Eversept Partners, LP | 165,000 | $2,116,950 | 1.15% |
| Artal Group S.A. | 2,150,000 | $27,585,000 | 1.02% |
| AlpInvest Partners B.V. | 26,925 | $345,000 | 0.99% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,654,865 | $21,232,000 | 0.85% |
| Lisanti Capital Growth, LLC | 142,760 | $1,832,000 | 0.74% |